News
MGRX
2.480
+1.64%
0.040
Weekly Report: what happened at MGRX last week (1216-1220)?
Weekly Report · 1d ago
Mangoceuticals, Inc. Acquires Patent for Mushroom-Derived Health Compositions to Expand Wellness Product Line
Barchart · 4d ago
Mangoceuticals Shares Rise 22%, Company Acquires Mushroom-Based Wellness and Innovations Patent
Dow Jones · 4d ago
Mangoceuticals Expands with Patent Acquisition in Nutraceuticals
TipRanks · 4d ago
MANGOCEUTICALS, INC. COMPLETES ACQUISITION OF MUSHROOM-BASED WELLNESS AND INNOVATIONS PATENT
Reuters · 4d ago
Weekly Report: what happened at MGRX last week (1209-1213)?
Weekly Report · 12/16 12:05
Weekly Report: what happened at MGRX last week (1202-1206)?
Weekly Report · 12/09 12:03
Mangoceuticals, Inc. (MGRX) Launches Investigation into Potential Stock Manipulation Following Reverse Stock Split
Barchart · 12/04 16:16
Mangoceuticals initiates investigation into potential stock manipulation
TipRanks · 12/04 12:10
MANGOCEUTICALS, INC. INITIATES INVESTIGATION INTO POTENTIAL STOCK MANIPULATION SCHEME FOLLOWING RECENT REVERSE STOCK SPLIT
Reuters · 12/04 12:05
Weekly Report: what happened at MGRX last week (1125-1129)?
Weekly Report · 12/02 12:04
Weekly Report: what happened at MGRX last week (1118-1122)?
Weekly Report · 11/25 11:53
Weekly Report: what happened at MGRX last week (1111-1115)?
Weekly Report · 11/18 11:49
Mangoceuticals Signs Consulting Deal with CFO Johnston
TipRanks · 11/12 22:29
Weekly Report: what happened at MGRX last week (1104-1108)?
Weekly Report · 11/11 12:07
Weekly Report: what happened at MGRX last week (1028-1101)?
Weekly Report · 11/04 12:03
Mangoceuticals regains full compliance with Nasdaq min bid price requirement
TipRanks · 10/31 12:15
Weekly Report: what happened at MGRX last week (1021-1025)?
Weekly Report · 10/28 11:53
BUZZ-U.S. STOCKS ON THE MOVE-Freeport-McMoRan, A.O. Smith, Genuine Parts
Reuters · 10/22 18:26
BUZZ-U.S. STOCKS ON THE MOVE-Lockheed Martin, General Motors, Philip Morris International
Reuters · 10/22 15:52
More
Webull provides a variety of real-time MGRX stock news. You can receive the latest news about Mangoceuticals, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About MGRX
Mangoceuticals, Inc. is primarily focused on developing, marketing, and selling a variety of men’s health and wellness products and services via a secure telemedicine platform. The Company has developed and is commercially marketing a new brand of erectile dysfunction (ED) products under the brand name Mango and a brand of hair loss products under the brand name Grow. These products are produced at a compounding pharmacy using a proprietary combination of United States Food and Drug Administration (FDA) approved ingredients and are available to patients on the determination of a prescribing physician that the compounded drug is necessary for the individual patient. It is marketing and selling these branded ED and hair loss products exclusively online via its Website at www.MangoRx.com. Its customer platform connects consumers to licensed healthcare professionals through its Website for the provision of care via telehealth. It also owns a global patent portfolio of oral solution.